Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
Contacts
Capabilities
Suggested News & Insights
Sidley Secures Unanimous Supreme Court Victory Reinforcing Constitutional Venue ProtectionsJune 12, 2026Prediction Market “Insider Trading” Revisited: Technology Employee Charged With Using Confidential Corporate Information to Profit from Event ContractsJune 12, 2026SDNY Signals Increased Scrutiny of Private Market ValuationsJune 11, 2026DOJ’s Civil Rights Fraud Initiative Raises False Claims Act Risks for Healthcare and Life Sciences CompaniesJune 10, 2026President Trump Issues Executive Order to Enhance Customs EnforcementJune 9, 2026Prediction Markets and Insider Trading: Why Organizations Should Update Compliance Policies NowJune 8, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
